Key result
A pharmacist-led transitions of care program did not significantly reduce 30-day all-cause hospital readmissions compared to historical controls in high-risk patients (aOR 0.78).
Why the study?
Does a multifaceted pharmacist-led transitions of care program reduce 30-day all-cause readmissions in primary care patients?
Cohort (n=256)
No
Does a multifaceted pharmacist-led transitions of care program reduce 30-day all-cause readmissions in primary care patients?
Odds Ratio: 0.78 (95% CI 0.21–2.89)
Absolute Event Rate: 13.5% vs 9.3%
p-value: p=0.71
A pharmacist-led transitions of care program implemented in a primary care setting did not significantly reduce 30-day all-cause readmissions compared to historical controls.
Pharmacist TOC pilot feasible in primary care; leaves open whether it improves outcomes in larger trials.
Pharmacists in primary care settings have unique opportunities to address the causes of ineffective care transitions. The objective of this study is to describe the implementation of a multifaceted pharmacist transitions of care (TOC) intervention integrated into a primary care practice and evaluate the effectiveness of the program. This was a two-phase pilot study describing the development, testing, and evaluation of the TOC program. In Phase 1, the TOC intervention was implemented in a general patient population, while Phase 2 focused the intervention on high-risk patients. The two pilot phases were compared to each other (Phase 1 vs. Phase 2) and to a historical control group of patients who received usual care prior to the intervention (Phase 1 and Phase 2 vs. control). The study included 138 patients in the intervention group (Phase 1: 101 and Phase 2: 37) and 118 controls. At baseline, controls had a significantly lower LACE index, shorter length of stay, and a lower number of medications at discharge, indicating less medical complexity. A total of 344 recommendations were provided over both phases, approximately 80% of which were accepted. In adjusted models, there were no significant differences in 30-day all-cause readmissions between Phase 2 and controls (aOR 0.78; 95% CI 0.21–2.89; p = 0.71) or Phase 1 (aOR 0.99; 95% CI 0.30–3.37; p = 0.99). This study successfully implemented a pharmacist-led TOC intervention within a primary care setting using a two-phase pilot design. More robust studies are needed in order to identify TOC interventions that reduce healthcare utilization in a cost-effective manner.
No takes yet. Share an insight, caveat, or question.
Slazak et al. (2020) conducted a cohort in Hospital discharge / Transitions of care (n=256). Pharmacist-led transitions of care (TOC) program vs. Usual care (historical control) was evaluated on 30-day all-cause hospital readmissions (aOR 0.78, 95% CI 0.21-2.89, p=0.71). A pharmacist-led transitions of care program did not significantly reduce 30-day all-cause hospital readmissions compared to historical controls in high-risk patients (aOR 0.78).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: